HTT update 20201023
- Version 13
- by (unknown)
- Version 14
- by (unknown)
Deletions or items before changed
Additions or items after changed
| 1 | + | [MainPage Wiki Main Page]
|
||
|---|---|---|---|---|
| 2 | + | |||
| 3 | + | [HTTupdates All Updates]
|
||
| 4 | ==HTT data-collection relaunch and project update. Help Needed. == | |||
| 5 | ==Update: October 23, 2020== | |||
| 6 | ||||
| 7 | Dear all, | |||
| 8 | ||||
| 9 | We are pleased to announce some recent accomplishments of the High-throughput truthing project (HTT) and request your assistance to maintain progress (HELP!). | |||
| 10 | ||||
| 11 | The HTT project's objective is to create a validation dataset fit for a regulatory purpose. Pursuing this objective is expected to inform regulatory frameworks and be instructive to others to develop their own validation datasets. | |||
| 12 | For more detailed information about the project and/or to register as a pathologist-data-collector, please visit https://ncihub.org/groups/eedapstudies/. | |||
| 13 | ||||
| 14 | '''HELP!''' We need more pathologist annotations and physical slides to complete our pilot study. | |||
| 15 | ||||
| 16 | Once the pandemic subsides, we are also hoping to recruit host sites for collecting microscope-mode data using the eeDAP platform ([http://spie.org/Publications/Journal/10.1117/1.JMI.1.3.037501 LINK to eeDAP manuscript], [https://github.com/DIDSR/eeDAP Link to eeDAP GitHub repo]). | |||
| 17 | ||||
| 18 | '''To contact us with any questions or join our efforts: [HTTContacts Contact Us HERE]''' | |||
| 19 | ||||
| 20 | __'''Accomplishments'''__ | |||
| 21 | ||||
| 22 | * Manuscript submitted and in pre-publication with the first results to the Journal of Pathology Informatics! | |||
| 23 | * Poster presentation: "A Pathologist-Annotated Dataset for Validating AI/ML: A Project Description and Pilot Study”, [Presentation:ProjectDescriptionandPilotStudy Link] | |||
| 24 | *Pre-Publication Link: https://arxiv.org/abs/2010.06995 | |||
| 25 | * We have developed pilot data and data aggregation pipelines. | |||
| 26 | * We have made progress on the development of statistical analysis plans. For a related presentation, [https://digitalpathologyalliance.org/jun-2020-alliance-at-siim-2020 click HERE]. | |||
| 27 | * We have submitted an inquiry to the FDA Medical Device Development Tool program, received feedback, and are drafting our response and full MDDT qualification plan. | |||
| 28 | * We have developed RCA (Research Collaboration Agreement- templates, for the template, click HERE. (https://ncihub.org/groups/eedapstudies/wiki/HighThroughputTruthingYear3) | |||
| 29 | * We have submitted an internal funding proposal to the FDA Office of Women’s Health. | |||
| 30 | * FDA has recruited Katherine Elfer, a NCI-FDA Cancer Prevention Fellowship Program / Interagency Oncology Task Force fellow, to work on this project. | |||
| 31 | ||||
| 32 | Thanks for all your support with spreading the word about what we do! For more details or questions, contact Katherine Elfer (Katherine.Elfer@fda.hhs.gov) and Brandon Gallas (Brandon.Gallas@fda.hhs.gov). | |||
| 33 | ||||
| 34 | The HTT Leadership Team, | |||
| 35 | ||||
| 36 | Brandon Gallas, FDA; Project Lead | |||
| 37 | ||||
| 38 | Katherine Elfer, FDA, Project Coordinator | |||
| 39 | ||||
| 40 | [[Image(emailgrabber.png, 350px)]] | |||